Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1975 Aug;32(2):160–167. doi: 10.1038/bjc.1975.145

Circulating levels of prolactin in human breast cancer.

N A Sheth, K J Ranadive, J N Suraiya, A R Sheth
PMCID: PMC2024836  PMID: 2274

Abstract

Serum prolactin concentrations were measured by radioimmunoassays in 98 patients with established carcinoma of breast, 12 patients with cystic mastitis and 10 patients with gynaecomastia and compared with that of age matched normal control women. The serum prolactin levels in the patients with breast cancer, gynaecomastia or cystic mastitis were observed to be similar to that in normal women. It was interesting to note that the levels of prolactin in the luteal phase of the cycle were higher than that in the early follicular phase in normal women.

Full text

PDF
160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINS H. J., FALCONER M. A., HAYWARD J. L., MACLEAN K. S., SCHURR P. H., ARMITAGE P. Adrenalectomy and hypophysectomy for advanced cancer of the breast. Lancet. 1960 May 28;1(7135):1148–1153. doi: 10.1016/s0140-6736(60)91039-4. [DOI] [PubMed] [Google Scholar]
  2. Boot L. M. Prolactin and mammary gland carcinogenesis. The problem of human prolactin. Int J Cancer. 1970 Mar 15;5(2):167–175. doi: 10.1002/ijc.2910050202. [DOI] [PubMed] [Google Scholar]
  3. Boyns A. R., Cole E. N., Griffiths K., Roberts M. M., Buchan R., Wilson R. G., Forrest A. P. Plasma prolactin in breast cancer. Eur J Cancer. 1973 Feb;9(2):99–102. doi: 10.1016/0014-2964(73)90078-9. [DOI] [PubMed] [Google Scholar]
  4. Ehara Y., Siler T., VandenBerg G., Sinha Y. N., Yen S. S. Circulating prolactin levels during the menstrual cycle: episodic release and diurnal variation. Am J Obstet Gynecol. 1973 Dec 1;117(7):962–970. doi: 10.1016/0002-9378(73)90069-0. [DOI] [PubMed] [Google Scholar]
  5. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Meites J., Lu K. H., Wuttke W., Welsch C. W., Nagasawa H., Quadri S. K. Recent studies on functions and control of prolactin secretion in rats. Recent Prog Horm Res. 1972;28:471–526. [PubMed] [Google Scholar]
  7. Midgley A. R., Jr Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology. 1966 Jul;79(1):10–18. doi: 10.1210/endo-79-1-10. [DOI] [PubMed] [Google Scholar]
  8. Mittra I., Hayward J. L., McNeilly A. S. Hypothalamic-pituitary-prolactin axis in breast cancer. Lancet. 1974 May 11;1(7863):889–891. doi: 10.1016/s0140-6736(74)90345-6. [DOI] [PubMed] [Google Scholar]
  9. Mittra I. Mammotropic effect of prolactin enhanced by thyroidectomy. Nature. 1974 Apr 5;248(448):525–526. doi: 10.1038/248525a0. [DOI] [PubMed] [Google Scholar]
  10. Nokin J., Vekemans M., L'Hermite M., Robyn C. Circadian periodicity of serum prolactin concentration in man. Br Med J. 1972 Sep 2;3(5826):561–562. doi: 10.1136/bmj.3.5826.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pearson O. H., Llerena O., Llerena L., Molina A., Butler T. Prolactin-dependent rat mammary cancer: a model for man? Trans Assoc Am Physicians. 1969;82:225–238. [PubMed] [Google Scholar]
  12. Sassin J. F., Frantz A. G., Weitzman E. D., Kapen S. Human prolactin: 24-hour pattern with increased release during sleep. Science. 1972 Sep 29;177(4055):1205–1207. doi: 10.1126/science.177.4055.1205. [DOI] [PubMed] [Google Scholar]
  13. Sheth N. A., Ranadive K. J., Sheth A. R. In vitro binding of radioiodinated human placental lactogen to murine mammary gland. Eur J Cancer. 1974 Oct;10(10):653–660. doi: 10.1016/0014-2964(74)90004-8. [DOI] [PubMed] [Google Scholar]
  14. Shiu R. P., Kelly P. A., Friesen H. G. Radioreceptor assay for prolactin and other lactogenic hormones. Science. 1973 Jun 1;180(4089):968–971. doi: 10.1126/science.180.4089.968. [DOI] [PubMed] [Google Scholar]
  15. Turkington R. W., Underwood L. E., Van Wyk J. J. Elevated serum prolactin levels after pituitary-stalk section in man. N Engl J Med. 1971 Sep 23;285(13):707–710. doi: 10.1056/NEJM197109232851302. [DOI] [PubMed] [Google Scholar]
  16. Vekemans M., Delvoye P., L'Hermite M., Robyn C. Evolution des taux sériques de prolactine au cours du cycle menstruel. C R Acad Sci Hebd Seances Acad Sci D. 1972 Nov 13;275(20):2247–2250. [PubMed] [Google Scholar]
  17. Wilson R. G., Buchan R., Roberts M. M., Forrest A. P., Boyns A. R., Cole E. N., Griffiths K. Plasma prolactin and breast cancer. Cancer. 1974 May;33(5):1325–1327. doi: 10.1002/1097-0142(197405)33:5<1325::aid-cncr2820330517>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  18. Yanai R., Nagasawa H. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice. J Natl Cancer Inst. 1972 Mar;48(3):715–719. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES